Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
Russian court extends detention of US reporter Gershkovich
Post Content Post Views: 122
Taiwan 2024 elections: These are the three parties vying to replace President Tsai Ing-Wen
The outcome of this election will likely influence testy U.S.-China ties and impact security in the broader Asia-Pacific region. Post Views: 114
UK budget winners and losers: the pound, bonds and brewers
Post Content Post Views: 118
U.S. business activity steady in November – S&P Global survey
Post Content Post Views: 109
BitMEX co-founder predicts Bitcoin surge amid dollar liquidity rise
Post Content Post Views: 106
US stocks mixed; Powell speech eyed for rates guidance
Post Content Post Views: 116